Ruxolitinib (5mg)
Jakavi 5 mg Tablet is used in the treatment of chronic idiopathic myelofibrosis.
14 tablets in 1 strip
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Jakavi 5 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Jakavi 5 mg Tablet is an anti-cancer medication. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.
Related Warnings
Interaction with alcohol is unknown. Please consult your doctor.
Jakavi 5 mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Jakavi 5 mg Tablet is probably unsafe to use during lactation. Limited human data suggest that the drug could represent a significant risk to the baby.
Jakavi 5 mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Jakavi 5 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 5 mg Tablet may be needed. Please consult your doctor.
Use of Jakavi 5 mg Tablet is not advised in patients with moderate to severe kidney disease.
Jakavi 5 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 5 mg Tablet may be needed. Please consult your doctor.
